Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Price:
2.6
USD
2.36%
Market Closed
Market Cap:
$187.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
|
US |
|
C
|
Corporate Office Properties Trust
F:WX7
|
US |
|
3
|
3M Co
XMUN:MMM
|
US |
|
I
|
Isabella Bank Corp
NASDAQ:ISBA
|
US |
|
U
|
United Utilities Group PLC
OTC:UUGWF
|
UK |
|
JD.Com Inc
HKEX:89618
|
CN |
|
MediaTek Inc
TWSE:2454
|
TW |
|
C
|
CVS Health Corp
SWB:CVS
|
US |
|
F
|
Ferrovial SA
LSE:0P2N
|
ES |
|
Blackrock Silver Corp
XTSX:BRC
|
CA |
|
Guillemot Corporation SA
F:GUL
|
FR |
|
Sompo Holdings Inc
OTC:SMPNY
|
JP |
|
InterContinental Hotels Group PLC
LSE:IHG
|
UK |
|
N
|
Nyocor Co Ltd
SSE:600821
|
CN |
|
Workday Inc
NASDAQ:WDAY
|
US |
|
M
|
Mitsubishi Corp
OTC:MSBHF
|
JP |
|
Evolution AB (publ)
OTC:EVGGF
|
SE |
|
Middleby Corp
NASDAQ:MIDD
|
US |
Wall St Price Targets
ABOS Price Targets Summary
Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals Inc
Wall Street analysts forecast ABOS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ABOS is 7.34 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
4.04
USD
55% Upside
Average Forecast
Price Target
7.34
USD
182% Upside
Highest Forecast
Price Target
10.5
USD
304% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABOS's stock price target?
Price Target
7.34
USD
7.34
USD
According to Wall Street analysts, the average 1-year price target for ABOS is 7.34 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
